iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionEllis Investment Partners, LLC
Latest Disclosed Ownership3,255 shares
Latest Disclosed Value $ 549,684
Ellis Investment Partners, LLC reports 1.85% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Ellis Investment Partners, LLC filed a 13F-HR form disclosing ownership of 3,255 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $549,684 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 3,196 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 1.85% during the quarter. The current value of the position is $426,568 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,255 59 1.85 550 1.86 0.0954
2026-02-02 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,196 -44 -1.36 540 15.42 0.0941
2025-10-22 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,240 -277 -7.88 468 5.18 0.0845
2025-07-25 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,517 13 0.37 445 -0.89 0.0864
2025-04-22 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,504 -167 -4.55 448 -7.63 0.0926
2025-01-30 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,671 -4 -0.11 485 -9.35 0.0956
2024-10-24 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,675 -486 -11.68 535 -6.30 0.1043
2024-08-06 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,161 -633 -13.20 571 -13.09 0.1209
2024-04-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,794 -1,032 -17.71 658 -16.94 0.1431
2024-01-29 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,826 -942 -13.92 791 -4.35 0.1839
2023-11-01 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,768 -35 -0.51 828 -4.17 0.2128
2023-08-07 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,803 -160 -2.30 864 -4.00 0.2115
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,963 -506 -6.77 899 -8.27 0.2320
2023-01-31 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,469 -1,237 -14.21 981 -3.73 0.2670
2022-11-14 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF ISHARES BIOTECH 464287556 8,706 -701 -7.45 1,018 -7.96 0.2821
2022-08-01 2022-06-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 9,407 -1,267 -11.87 1,106 -20.43 0.2969
2022-05-03 2022-03-31 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 10,674 -12,698 -54.33 1,390 -61.03 0.3277
2022-02-01 2021-12-31 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 23,372 -12 -0.05 3,567 -5.63 0.8188
2021-10-21 2021-09-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 23,384 169 0.73 3,780 -0.50 0.9551
2021-07-26 2021-06-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 23,215 -2,328 -9.11 3,799 -1.22 0.9691
2021-05-03 2021-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 25,543 1,553 6.47 3,846 5.83 1.0704
2021-01-20 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 23,990 3,972 19.84 3,634 34.10 1.1033
2020-10-19 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 20,018 929 4.87 2,710 3.36 0.9516
2020-07-13 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 19,089 -1,673 -8.06 2,622 21.73 0.9835
2020-04-17 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 20,762 5,434 35.45 2,154 17.26 1.0225
2020-01-07 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 15,328 387 2.59 1,837 25.48 0.6136
2019-10-09 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 14,941 -260 -1.71 1,464 -12.23 0.5312
2019-07-24 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 15,201 -258 -1.67 1,668 -3.58 0.6234
2019-04-25 2019-03-31 13F/A-2 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 15,459 -1,022 -6.20 1,730 6.92 0.7008
2019-04-24 2019-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 1,761,815 1,746,356 1,761 0.6518
2019-01-29 2018-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 16,481 16,481 1,618 0.7380
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.